Drug Profile
Amlodipine/rosuvastatin/telmisartan - Daewon Pharmaceutical
Alternative Names: DW-1501Latest Information Update: 22 Oct 2020
Price :
$50
*
At a glance
- Originator Daewon Pharmaceutical
- Class Antihyperlipidaemics; Antihypertensives; Benzimidazoles; Benzoates; Dihydropyridines; Fluorobenzenes; Ischaemic heart disorder therapies; Pyrimidines; Small molecules; Sulfonamides
- Mechanism of Action ACE inhibitors; Angiotensin type 2 receptor antagonists; Calcium channel antagonists; Cytochrome P 450 enzyme system inhibitors; HMG-CoA reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Dyslipidaemias; Hypertension